News

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.
Johnson & Johnson's (J&J) human neonatal Fc receptor (FcRn)-blocking monoclonal antibody Imaavy (nipocalimab-aahu) has ...
While Johnson & Johnson isn't the first to secure FDA approval for an FcRn-blocking antibody in myasthenia gravis, the New ...
Judy George covers neurology and neuroscience news for MedPage Today. She writes about brain aging, Alzheimer’s disease, dementia, MS, rare diseases, epilepsy, autism, headache, stroke ...
Could he see more chosen before him as his wait extends into Saturday ... of the Titans' eye in the lead-up to the 2025 NFL Draft after he starred in his lone season with the Hurricanes.
The “Deadpool” star appeared to offer some words of encouragement — and a couple of quick smooches — to his wife, Blake Lively, moments before she gave an emotional speech at the Time100 ...
Bre'Andrea Wiley, 19, vanished in January 2022, just weeks before she was scheduled to serve ... but why did the system wait so long to stop this man? After years of reporting his erratic behavior ...
Richard J. Nowak, MD, MS, Yale School of Medicine, explains what some early myasthenia gravis symptoms are and their impact on research efforts. Revisit part 1 of this interview, where Nowak ...
A big question remains in the minds of people: for more benefits, should watermelon be eaten before or after eating food? Morning is the best time to eat watermelon. Eating it for breakfast on an ...
The Ministry of Food and Drug Safety noted on the 24th that it will approve the use of the systemic Myasthenia Gravis treatment, Listigoju (Rozanolixizumab). Myasthenia Gravis is a rare disease ...
In an interview with CBS Sports before Thursday's draft ... also named Academic All-American of the Year this past season after securing first-team Academic All-America honors for a second ...